Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment
Cell Proliferation · 2024-05 · 57 (5)
DOI: 10.1111/cpr.13592 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 29.12.2023. Verfasst von Xiangjian Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Dingli Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Single-Cell Analysis, Sequence Analysis, RNA, Tumor Microenvironment. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Science and Technology Plan Project of Wenzhou Municipality.
Abstract (Originalsprache)
Cancer‐associated fibroblasts (CAFs), a phenotypically and functionally heterogeneous stromal cell, are one of the most important components of the tumour microenvironment. Previous studies have consolidated it as a promising target against cancer. However, variable therapeutic efficacy—both protumor and antitumor effects have been observed not least owing to the strong heterogeneity of CAFs. Over the past 10 years, advances in single‐cell RNA sequencing (scRNA‐seq) technologies had a dramatic effect on biomedical research, enabling the analysis of single cell transcriptomes with unprecedented resolution and throughput. Specifically, scRNA‐seq facilitates our understanding of the complexity and heterogeneity of diverse CAF subtypes. In this review, we discuss the up‐to‐date knowledge about CAF heterogeneity with a focus on scRNA‐seq perspective to investigate the emerging strategies for integrating multimodal single‐cell platforms. Furthermore, we summarized the clinical application of scRNA‐seq on CAF research. We believe that the comprehensive understanding of the heterogeneity of CAFs form different visions will generate innovative solutions to cancer therapy and achieve clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Dingli Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Surgical Oncology, Wenzhou Central Hospital, Wenzhou, Zhejiang, China.
- The Second Affiliated Hospital of Shanghai University, Wenzhou, Zhejiang, China.
- Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- School of Medicine, Shanghai University, Shanghai, China.
- Institute of Translational Medicine, Shanghai University, Shanghai, China.
ORCID-Profile: Ke Xu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
- Science and Technology Plan Project of Wenzhou Municipality
- Shanghai Pudong New Area Science and Technology Development Fund for the People's Livelihood Research Project
Zitieren
APA
Zhang, X., Zhu, R., Yu, D., Wang, J., Yan, Y., & Xu, K. (2024). Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment. Cell Proliferation, 57(5). https://doi.org/10.1111/cpr.13592
Vancouver
Zhang X, Zhu R, Yu D, Wang J, Yan Y, Xu K. Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment. Cell Proliferation. 2024;57(5). doi:10.1111/cpr.13592
BibTeX
@article{Zhang2024,
author = {Zhang, Xiangjian and Zhu, Ruiqiu and Yu, Die and Wang, Juan and Yan, Yuxiang and Xu, Ke},
title = {Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment},
journal = {Cell Proliferation},
year = {2024},
volume = {57},
number = {5},
doi = {10.1111/cpr.13592}
}
EUVIMED